CONSENSUS
№1
Consensus for the management of patients with type 2 diabetes in combination with cardiorenal diseases
Mankovsky B. M., Bilchenko O. V., Zinych O. V., Ivanov D. D., Irkin O. I., Komisarenko Yu. I., Kushnirenko S. V., Lutay Ya. M., Mishchenko L. A., Pertseva N. O., Protsiuk O. V., Saenko Ya. A., Smirnov I. I., Sokolova L. K., Urbanovych A. M., Yuzvenko T. U., Yagensky A. V.
8-21
NEW RESEARCH
№2
Empagliflozin and decreased risk of nephrolithiasis: a potential new role for SGLT2 inhibition?
Priyadarshini Balasubramanian, Christoph Wanner, João Pedro Ferreira, Anne Pernille Ofstad, Amelie Elsaesser, Bernard Zinman, Silvio E Inzucchi
DOI: https://doi.org/10.1210/clinem/dgac154
22-29
№3
The role of DPP-4 inhibitors in the treatment of patients with type 2 diabetes mellitus
Sayenko Ya., Nagybyn V., Mankovsky B.
30-37
№4
Hypoglycemia in patients with COVID-19: an incidental clinical finding or a normal outcome of treatment?
Mankovskyi B.M., Halushko O.A., Protsiuk O.V., Pogorila O.I. Shupyk National University of Health Care of Ukraine, Kyiv, Ukraine
38-50
№5
Pathological changes in the vessels of the lower extremities in obese patients
Lahoda D., Velychko V., Danylchuk H., Venher Y., Malcheniuk D.
51-59